[Use of adrenergic alpha receptor blockaders (phenoxybenzamine) for the treatment of cardiogenic shock complicating the course of myocardial infarct, under clinical and experimental conditions].
D000818:Animals; D002415:Cats; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000150:complications / Q000188:drug therapy*
D010643:Phenoxybenzamine
Primenenie blokatora alfa-adrenergicheskikh retseptorov (fenoksibenzamina) dlia lecheniia kardiogennogo shoka, oslozhnivshego techenie infarkta miokarda, v usloviiakh eksperimenta i kliniki.